investors.dna.com

Investors | Overview | Intrexon

Operating Units and Divisions. Agaricus and Neurospora Platforms. Intrexon Institute for Biomolecular Research. Approach to synthetic biology has the potential to provide new, more effective and sustainable solutions to address these challenges. 160; 2.49. Data as of 08/14/15 4:00 pm ET. Minimum 20 minute delay. Intrexon Corporate Presentation August 2015. Intrexon Jefferies Healthcare Presentation June 2015. IRS Form 8937 Related to Special Stock Dividend of ZIOPHARM Shares. Intrexon to Acquire Oxitec, ...

http://investors.dna.com/

OVERVIEW OF investors.dna.com

TRAFFIC RANK

>1,000,000

REVIEWS

0

PAGES IN THIS WEBSITE

0

LINKS TO THIS WEBSITE

CONTACTS

ADDRESSES

SOCIAL LINKS

ONLINE SINCE

WEBSITE DETAILS

SEO

PAGES

SIMILAR SITES

TRAFFIC RANK FOR INVESTORS.DNA.COM

TODAY'S RATING

>1,000,000

TRAFFIC RANK - AVERAGE PER MONTH

BEST MONTH

October

AVERAGE PER DAY Of THE WEEK

HIGHEST TRAFFIC ON

Saturday

TRAFFIC BY CITY

Sign up

CUSTOMER REVIEWS

Average Rating: 4.8 out of 5 with 10 reviews

5 star

8

4 star

2

3 star

0

2 star

0

1 star

0

Hey there! Start your review of investors.dna.com

AVERAGE USER RATING

Write a Review

WEBSITE PREVIEW

LOAD TIME

0.8 seconds

CONTACTS AT INVESTORS.DNA.COM

ADD CONTACT

Login

TO VIEW CONTACTS

Remove Contacts

FOR PRIVACY ISSUES

CONTENT

PAGES IN
THIS WEBSITE

0

SSL

EXTERNAL LINKS

25

SITE IP

128.177.96.16

LOAD TIME

0.781 sec

SCORE

6.2

PAGE TITLE

Investors | Overview | Intrexon | investors.dna.com Reviews

<META> DESCRIPTION

Operating Units and Divisions. Agaricus and Neurospora Platforms. Intrexon Institute for Biomolecular Research. Approach to synthetic biology has the potential to provide new, more effective and sustainable solutions to address these challenges. 160; 2.49. Data as of 08/14/15 4:00 pm ET. Minimum 20 minute delay. Intrexon Corporate Presentation August 2015. Intrexon Jefferies Healthcare Presentation June 2015. IRS Form 8937 Related to Special Stock Dividend of ZIOPHARM Shares. Intrexon to Acquire Oxitec, ...

<META> KEYWORDS

1 synthetic biology

2 our platform

3 subsidiaries

4 management

5 board of directors

6 our commitment

7 technologies

8 ultravector

9 rheoswitch

10 cell systems informatics

CONTENT

Page content here

KEYWORDS ON PAGE

synthetic biology,our platform,subsidiaries,management,board of directors,our commitment,technologies,ultravector,rheoswitch,cell systems informatics,protein engineering,attsite,recombinases,leap,antibody discovery,endometrial regenerative cells,beyondbio

CONTENT-TYPE

utf-8

GOOGLE PREVIEW

Investors | Overview | Intrexon | investors.dna.com Reviews

https://investors.dna.com

Operating Units and Divisions. Agaricus and Neurospora Platforms. Intrexon Institute for Biomolecular Research. Approach to synthetic biology has the potential to provide new, more effective and sustainable solutions to address these challenges. 160; 2.49. Data as of 08/14/15 4:00 pm ET. Minimum 20 minute delay. Intrexon Corporate Presentation August 2015. Intrexon Jefferies Healthcare Presentation June 2015. IRS Form 8937 Related to Special Stock Dividend of ZIOPHARM Shares. Intrexon to Acquire Oxitec, ...

LINKS TO THIS WEBSITE

dna.com

Careers | Intrexon

http://www.dna.com/Careers

Operating Units and Divisions. Neurospora and Agaricus Platforms. Office of Academic Alliances and Technology Licensing. We are always seeking those who share our passion for excellence, hard work, game changing creativity, and moving beyond the limitations of traditional biotech. With Intrexon, you will have an exceptional opportunity to contribute directly to the future of the field. Industrial Products Division – South San Francisco, California and Budapest, Hungary. View Current Job Openings. Questio...

dna.com

Markets | Intrexon

https://www.dna.com/Markets

Operating Units and Divisions. Neurospora and Agaricus Platforms. Office of Academic Alliances and Technology Licensing. Operating Units and Divisions. Neurospora and Agaricus Platforms. Intrexon Institute for Biomolecular Research. Web Solution by IDD, Inc.

dna.com

Collaborations | Intrexon

https://www.dna.com/Collaborations/Overview

Operating Units and Divisions. Neurospora and Agaricus Platforms. Office of Academic Alliances and Technology Licensing. Intrexons technology platform enables novel approaches offering our partners a competitive edge in time to market, cost of production, quality of end product, and an ability to address challenging issues across various markets. Our business model is to commercialize our technologies through exclusive channel collaborations and joint ventures with collaborators that have industry ex...

dna.com

Joint Ventures | Intrexon

https://www.dna.com/Collaborations/Joint-Ventures

Operating Units and Divisions. Neurospora and Agaricus Platforms. Office of Academic Alliances and Technology Licensing. In certain strategic circumstances, Intrexon enters into a joint venture with an ECC partner. Intrexon has executed three such joint venture agreements to date:. S and I Ophthalmic. Is a joint venture between Sun Pharmaceutical Industries Ltd. Platform for the treatment of ocular diseases . Is a joint venture between OvaScience, Inc. Intrexon Energy Partners II. Based antigen-specific ...

dna.com

Health | Intrexon

https://www.dna.com/Markets/Health

Operating Units and Divisions. Neurospora and Agaricus Platforms. Office of Academic Alliances and Technology Licensing. Through our Better DNA. Approach, Intrexon is currently enabling collaborators to develop targeted gene therapy applications and novel solutions within oncology, rare skin disorders, active pharmaceutical ingredients, ocular diseases, human infertility, infectious diseases, and animal health. GI and Oral Diseases. Graft versus Host Disease. Available opportunities span multiple areas.

dna.com

Management | Intrexon

https://www.dna.com/Company/Management

Operating Units and Divisions. Neurospora and Agaricus Platforms. Office of Academic Alliances and Technology Licensing. Randal J. Kirk - Chairman and Chief Executive Officer. Andrew J. Last, Ph.D. - Chief Operating Officer. Thomas D. Reed, Ph.D. - Founder and Chief Science Officer. Rick L. Sterling - Chief Financial Officer. Donald P. Lehr - Chief Legal Officer. Jack A. Bobo - Chief Communications Officer, Senior Vice President. Thomas P. Bostick. Andy Bass - Senior Vice President, Consumer Sector.

dna.com

Energy | Intrexon

https://www.dna.com/Markets/Energy

Operating Units and Divisions. Neurospora and Agaricus Platforms. Office of Academic Alliances and Technology Licensing. Powering the Bioindustrial Revolution with Better DNA™. Intrexons proprietary methanotroph bioconversion platform holds the potential to transform the gas-to-liquids industry by generating valuable fuels and chemicals at a fraction of the costs of more traditional conversion methods. Discover more in Intrexons Pioneering Natural Gas-to-Liquids Bioconversion Platform video here:.

dna.com

Exclusive Channel Collaborations | Intrexon

https://www.dna.com/Collaborations/Exclusive-Channel-Collaborations

Operating Units and Divisions. Neurospora and Agaricus Platforms. Office of Academic Alliances and Technology Licensing. Intrexon provides expertise in the engineering, construction and modification of gene programs and cellular systems, where license to its cutting-edge synthetic biology tools and integrated technology suite give partners a competitive advantage towards a successful product launch. To discuss Exclusive Channel Collaboration opportunities. Available opportunities span multiple areas.

UPGRADE TO PREMIUM TO VIEW 17 MORE

TOTAL LINKS TO THIS WEBSITE

25

OTHER SITES

investors.diebold.com

Diebold | Investor Overview

Sign Up For Email Alerts. There are currently no events scheduled. Q2 2015 Diebold Earnings Conference Call. Thursday, July 30, 2015 8:30 am ET. Click here for webcast. Diebold Direct Stock Purchase Plan. Investor Relations Department 9-B-16. Wells Fargo Shareowner Services. St Paul, MN 55164-0874. 651-450-4064 (if outside the U.S.). Technology Strategy and Innovation Committee. Data provided by Nasdaq. Minimum 15 minutes delayed. CA Supply Chains Act. 2015 Diebold, Incorporated.

investors.diffusionpharma.com

Diffusion Pharmaceuticals Inc. | Investor Overview

Overview / Trans Sodium Crocetinate (TSC). Annual Meeting and Proxy Materials. Overview / Trans Sodium Crocetinate (TSC). Annual Meeting and Proxy Materials. Annual Meeting and Proxy Materials. Diffusion Pharmaceuticals is a clinical stage company focused on improving the effectiveness of standard-of-care therapies for life-threatening treatment-resistant solid cancerous tumors, without adding harmful side effects. December 12, 2016. November 14, 2016. November 08, 2016. Tuesday, June 21, 2016. THE SITE ...

investors.dime.com

Corporate Profile

News and Market Data. Dime Community Bancshares, Inc. Market Capital ( $. As of January 12, 2017 11:37 AM ET. Kirk Lloyd promoted to Chief Lending Officer Commercial Real Estate. Stuart H. Lubow Joins Dime as Senior Executive Vice President and head of Business Banking. Dime Community Bancshares to Release Earnings on January 26, 2017. Dime Community Bancshares, Inc. Brooklyn, NY 11211. 718) 782-6200 ext. 5260. American Stock Transfer and Trust Co. Brooklyn, NY 11219. S&P Global Market Intelligence.

investors.dineequity.com

DineEquity,Inc. - Investor Relations - Disclaimer

Â 2015 DineEquity, Inc.Â.

investors.discountbank.co.il

Israel Discount Bank - Investor Relations

Israel Discount Bank is a leading financial group in Israel. With nation-wide coverage and a strong domestic franchise, the Bank provides a full spectrum of corporate and retail financial products and services to its clients, both in Israel and in key financial centers around the world. Q2 2015 Conference Call. To join the Bank's presentation click here. 44 (0) 1452 555566. Please provide your name and company's name to the operator. Q2 -15 Financial Results and Conference Call. Q1 2015 Conference Call.

investors.dna.com

Investors | Overview | Intrexon

Operating Units and Divisions. Agaricus and Neurospora Platforms. Intrexon Institute for Biomolecular Research. Approach to synthetic biology has the potential to provide new, more effective and sustainable solutions to address these challenges. 160; 2.49. Data as of 08/14/15 4:00 pm ET. Minimum 20 minute delay. Intrexon Corporate Presentation August 2015. Intrexon Jefferies Healthcare Presentation June 2015. IRS Form 8937 Related to Special Stock Dividend of ZIOPHARM Shares. Intrexon to Acquire Oxitec, ...

investors.dolphingeo.com

Welcome to Dolphin Group | Dolphin Group

Welcome to Dolphin Group. No front page content has been created yet. In cooperation with Alert IR.

investors.dom.com

Dominion Resources Inc. -Investor Relations Highlights

Email Alerts, Requests. Event and Web Coverage. Video and Audio Downloads. Heating and Cooling Assistance. Strong Men and Women. VA Energy Conservation Program. NC Energy Conservation Program. NC Lakes and Recreation. Doing Business With US. Electric Trans. Access. Electric Trans. Projects. Call Before You Dig. List of Power Stations. Natural Gas and Liquids. Dominion Transmission, Inc. Recognizing a Natural Gas Emergency. Responding to a Natural Gas Emergency. Recognizing a Liquid Emergency.

investors.dominos.co.uk

Investor Relations Overview | Domino's Pizza Group plc

Skip to main content. Domino's Pizza Group plc. Section 430(2B) Companies Act. Results, Reports and Presentations. For the latest report. Delayed by at least 15 minutes. Interim Results for the 26 Weeks Ended 2. Appointment of Non-executive Director. Interim Results for the 26 Weeks Ended 28 June 2015. Preliminary Results for the 52 weeks ended 28 December 2014. 5 year financial summary. 5 year financial summary. Section 430(2B) Companies Act. Results, Reports and Presentations.

investors.dothill.com

Dot Hill Systems Corp. - Overview

Find Us on Facebook. Follow Us on Twitter. Watch Us on YouTube. Sign Up for Our Newsletter. Stock Quote (NASDAQ: HILL). 4:00 PM ET on Aug 7, 2015. Delayed at least 20 minutes. Aug 6, 2015. Dot Hill Reports Second Quarter 2015 Results and Updates 2015 Guidance. Aug 5, 2015. Dot Hill Invites Attendees of Flash Memory Summit to Learn About Real Value Provided By Real-Time Hybrid Storage. Jul 29, 2015. Dot Hill Enhances AssuredSAN Portfolio With New High-Capacity Hard Disk Drives. Jul 22, 2015. Jul 21, 2015.

investors.dqentertainment.com

DQ Entertainment PLC - Investor Relations

Welcome to Investor Relations. DQE produces traditional 2D animation, Digital animation, 3D animation, CGI, Visual Effects (VFX), Game Art, Game animation for PS, Xbox, Nintendo Wii and many more. DQE is currently developing its own Intellectual Property in animation and live action. The company has been on a high growth trajectory and has achieved many major accomplishments in business, with investors, plus knowledge and learning segments. Appointment of Non-Executive Director. Shall be Reproduced witho...